戻る Agenda
Session 4: Definitions and Concepts for Drug Safety
Session Chair(s)
William Gregory, PHD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
- This session will clarify important concepts, terms, and regulatory expectations in the context of interventional clinical trials. International consensus terms and definitions will be discussed, particularly those relevant to the US and EU.